Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Andrea Josephine Strang has worked on the following 47 EPO patent applications which have been published in the last five years:

EP12184700

Organic compounds

IPC classification:
A61K 31/427, A61K 31/4439, A61P 35/00, C07D 471/04, C07K 5/06
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12710794

FLUOROPHENYL BICYCLIC HETEROARYL COMPOUNDS

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12718554

17ALPHA-HYDROXYLASE/C17,20-LYASE INHIBITORS

IPC classification:
A61K 31/4436, A61K 31/4439, A61K 31/444, A61K 31/506, A61P 35/00, C07D 401/04, C07D 401/14, C07D 405/04, C07D 409/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12730043

HETEROCYCLIC SULFONAMIDE DERIVATIVES

IPC classification:
A61K 31/343, A61P 35/00, C07D 307/82
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12728089

CYCLOHEXYL ISOQUINOLINONE COMPOUNDS

IPC classification:
A61K 31/47, A61P 35/00, C07D 217/04, C07D 405/08
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12772493

BICYCLIC HETEROCYCLE DERIVATIVES FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

IPC classification:
A61K 31/4162, A61K 31/4188, A61P 9/12, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12769172

6 - SUBSTITUTED 3 - (QUINOLIN- 6 - YLTHIO) - [1,2,4]TRIAZOLO [4, 3 -A]PYRADINES AS TYROSINE KINASE

IPC classification:
A61K 31/437, A61P 29/00, A61P 35/00, C07D 471/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP12780535

CHOLINE SALT OF AN ANTI - INFLAMMATORY SUBSTITUTED CYCLOBUTENEDIONE COMPOUND

IPC classification:
A61K 31/18, A61P 29/00, C07C 215/40, C07C 311/48
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11725110

BIPHENYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES

IPC classification:
A61K 31/4184, A61P 5/00, C07D 235/30, C07D 401/04, C07D 403/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11725116

PIPERIDINYL SUBSTITUTED 1,3-DIHYDRO-BENZOIMIDAZOL-2-YLIDENEAMINE DERIVATIVES

IPC classification:
A61K 31/4184, A61P 5/00, C07D 235/30, C07D 401/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805775

PYRAZOLOPYRROLIDINE COMPOUNDS

IPC classification:
A61K 31/4162, A61K 31/4439, A61K 31/506, A61K 31/513, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12813983

CYCLIC UREA DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4184, A61K 31/4188, A61P 5/26, A61P 35/00, C07D 235/02, C07D 235/26, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/12, C07D 409/04, C07D 491/052
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805897

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61K 31/501, A61K 31/506, A61K 31/513, A61K 31/519, A61P 35/00, C07D 401/10, C07D 401/14, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 513/02
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805893

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61P 35/00, C07D 401/10, C07D 401/14, C07D 405/14, C07D 409/14, C07D 413/14
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805896

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61P 35/00, C07D 401/10
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805895

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61P 35/00, C07D 401/10, C07D 409/14
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805894

COMPOUNDS FOR INHIBITING THE INTERACTION OF BCL2 WITH BINDING PARTNERS

IPC classification:
A61K 31/4725, A61K 31/496, A61P 35/00, C07D 401/10, C07D 401/14, C07D 413/14
Applicant:
Novartis AG
Agent:
D Young & Co LLP
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13711952

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP12729549

HYDROXY SUBSTITUTED ISOQUINOLINONE DERIVATIVES AS P53 (MDM2 OR MDM4) INHIBITORS

IPC classification:
A61K 31/47, A61P 35/00, C07D 217/24, C07D 401/04, C07D 401/10, C07D 401/14, C07D 405/10, C07D 405/14, C07D 409/10, C07D 413/08, C07D 451/02, C07D 451/14, C07D 491/08, C07D 493/08
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13734183

PYRROLOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/407, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP10792944

SUBSTITUTED ISOQUINOLINONES AND QUINAZOLINONES

IPC classification:
A61K 31/495, A61P 35/00, C07D 217/24, C07D 401/04, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/04, C07D 405/12, C07D 405/14, C07D 409/12, C07D 413/10, C07D 413/12, C07D 413/14, C07D 417/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13814360

PYRIDONE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF TUBERCULOSIS

IPC classification:
A61K 31/4412, A61P 31/06, C07D 213/64, C07D 401/06, C07D 405/06
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP10779562

BENZENE-FUSED 6-MEMBERED OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES OF BICYCLIC HETEROARYLS

IPC classification:
A61K 31/4985, A61K 31/519, A61K 31/537, A61K 31/541, A61P 35/00, C07D 487/04, C07D 513/08
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12700840

SUBSTITUTED BI-HETEROARYL COMPOUNDS AS CDK9 INHIBITORS AND THEIR USES

IPC classification:
A61K 31/444, A61K 31/505, A61K 31/553, A61P 9/00, A61P 29/00, A61P 31/18, A61P 35/00, A61P 37/00, C07D 213/74, C07D 401/04, C07D 405/14, C07D 413/14, C07D 491/107
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14703441

SUBSTITUTED PURINONE COMPOUNDS

IPC classification:
C07D 473/28
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14704909

PYRAZOLO[3,4-D]PYRIMIDINONE COMPOUNDS AS INHIBITORS OF THE P53/MDM2 INTERACTION

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14708992

BENZOTHIOPHENE DERIVATIVES AND COMPOSITIONS THEREOF AS SELECTIVE ESTROGEN RECEPTOR DEGRADERS

IPC classification:
A61K 31/381, A61P 35/00, C07D 333/64, C07D 333/66, C07D 409/04, C07D 409/10, C07D 409/12, C07D 413/04, C07D 413/12, C07D 417/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11705532

DIMERIC IAP INHIBITORS

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/14, C07K 5/06
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11761540

17aHYDROXYLASE/C17,20-LYASE INHIBITORS

IPC classification:
A61K 31/435, A61K 31/4725, A61P 35/00, C07D 401/04, C07D 471/04, C07D 471/14, C07D 495/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11796696

DIMERIC IAP INHIBITORS

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14728350

PYRAZOLO-PYRROLIDIN-4-ONE DERIVATIVES AS BET INHIBITORS AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4162, A61K 31/437, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14731799

PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4162, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
PATENT GRANTED
EP14741368

PYRAZOLO-PYRROLIDIN-4-ONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4439, A61K 31/444, A61K 31/506, A61P 3/00, A61P 31/00, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP14731798

IMIDAZOPYRROLIDINONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11796695

DIMERIC IAP INHIBITORS

IPC classification:
A61K 31/4439, A61P 35/00, C07D 401/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11707115

PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6

IPC classification:
A61K 31/519, A61P 35/00, C07B 59/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12704039

[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE COMPOUNDS AS INHIBITORS OF THE C-MET TYROSINE KINASE

IPC classification:
A61K 31/5025, A61P 29/00, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11811150

BI-HETEROARYL COMPOUNDS AS VPS34 INHIBITORS

IPC classification:
A61K 31/505, A61P 35/00, C07D 239/42, C07D 401/12
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10790407

Heterocyclic sulfonamide derivatives

IPC classification:
A61K 31/343, A61K 31/423, A61P 29/00, A61P 35/00, C07D 263/56, C07D 307/79
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16161001

IMIDAZOPYRROLIDINONE COMPOUNDS

IPC classification:
A61K 31/4188, A61P 35/00, C07D 487/04
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP14812645

PYRROLOPYRROLONE DERIVATIVES AND THEIR USE AS BET INHIBITORS

IPC classification:
A61K 31/407, A61P 35/00, C07D 487/04, C07D 519/00
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15703106

1 -(TRIAZIN-3-YI_/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/495, A61P 35/04, C07D 241/26, C07D 249/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP15703105

1 -PYRIDAZIN-/TRIAZIN-3-YL-PIPER(-AZINE)/IDINE/PYROLIDINE DERIVATIVES AND AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/4965, A61K 31/505, C07D 239/48, C07D 241/26, C07D 249/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP15703321

N-AZASPIROCYCLOALKANE SUBSTITUTED N-HETEROARYL COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2

IPC classification:
A61K 31/495, A61P 35/04, C07D 241/18, C07D 241/20
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP12184747

Intermediate compounds for preparing SMAC peptidomimetics

IPC classification:
C07D 417/04, C07K 5/06
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15766661

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

IPC classification:
A61K 31/501, A61P 35/00, C07D 305/06, C07D 405/12, C07D 405/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made
EP15766660

COMPOUNDS AND COMPOSITIONS AS RAF KINASE INHIBITORS

IPC classification:
A61K 31/5377, A61P 35/00, C07D 213/74, C07D 403/12, C07D 413/04, C07D 413/14
Applicant:
Novartis AG
Agent:
Andrea Josephine Strang, Novartis Pharma AG
Status:
Request for examination was made

Please Sign in to use this feature